The global Sacral Nerve Stimulation (SNS) Market is expected to be around $3.3 billion by 2025. The market is primarily driven by factors such as increasing incidence of neurological disorders around the world, rising geriatric population along with increase in the investment for development of sacral nerve stimulation products by the key players in the market. Moreover, increase in the number of patients suffering from overactive bladder (OAB) condition is also expected to largely contribute to the market growth over the forecast period. However, factors such as unfavorable reimbursement policies and side-effects associated with SNS devices can hinder the market growth during the forecast period.

Download PDF Brochure of this report: https://www.crystalmarketresearch.com/pdfdownload/HC06144

The sacral nerve stimulator device is implanted under the skin specifically in the upper buttock area. The device consists of an implantable pulse generator. A lead is positioned near the sacral nerve in the lower back through which, a mild electric impulse is delivered which can positively influence the pelvic floor muscles and the rectal sphincters. Before the implantation of the permanent device, patients usually undergo a test to analyze the impact of nerve stimulation in terms of potential response from the patients. The observations from the test are analyzed to determine whether the patient is an appropriate candidate for implanting the permanent device. Implantable SNS devices segment held a significant share of the overall market in 2016 owing to their widespread applications for conditions such as fecal and urine incontinence.

The key players operating in the global sacral nerve stimulation market focus on product development and approvals in order to introduce advanced SNS solutions for effectively treating patients suffering from incontinence and secure a larger share of the global market. For instance, in February 2017, Nuvectra Corporation filed regulatory submission with the FDA in the U.S. and with the CE Mark authorities in the Europe for its Virtis sacral nerve stimulation (SNS) system. Medtronic plc has a dominant share in this market with its strong product portfolio and distribution network. Some of the key players operating in this market are, Axonics Modulation Technologies, Inc, Medtronic plc, Nuvectra Corporation and Cogentix Medical.

Get sample copy of this Report: https://www.crystalmarketresearch.com/report-sample/HC06144

Key Market Players:

Axonics Modulation Technologies Inc
Medtronic plc
Nuvectra Corporation
Cogentix Medical.

Table of Contents:

Introduction
Executive Summary
Market Overview
Sacral Nerve Stimulation Market, By Product
Sacral Nerve Stimulation Market, By Application
Sacral Nerve Stimulation Market, By Region
Company Profiles

Buy Report: https://www.crystalmarketresearch.com/checkout/HC06144

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:

Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States

Toll Free: +1-888-213-4282
Email: [email protected]
Blog: blog.crystalmarketresearch.com
Website: www.crystalmarketresearch.com